GUYS! DO NOT SELL YOUR SHARES there is heavy
GUYS!
DO NOT SELL YOUR SHARES
there is heavy manipulation going on here, the bigs are trying to press down share prices to keep them as low as possible for as long as possible. They do this buy dumping 10s of millions of shares to keep prices at bid/ask for prolonged periods of time. This tactic CANNOT LAST FOREVER. THEY WILL BE FORCED TO CEASE OR CHASE at a certain point
DO NOT SELL YOUR SHARES
Luxuriant will be fine, they are one of few companies serving this niche of the mmj sector, the others are trading in the dollars.
I get it, they have a shady past. However, they are have to be moronically insane to stake their future reputation on a sham, especially in the hottest sector in the game where there is REAL MONEY to be made.
Trust in Vortex, trust in Luxuriant.
Weak hands get slaughtered. If you feel like you are holding the bag at .0018 to .0025 then this is your opportunity to load low and bring down your average pps holdings.
WE'RE GOING TO BE FINE. relax
ProTek Capital Inc. (PRPM) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Hyzon Motors Announces Delisting from Nasdaq Hyzon Motors Inc. is making a significant shift regarding its stock trading status. This U.S. company, known for its commitment to high-performance hydrogen fuel cell technology, has decided to inform Nasdaq Stock Market of its intent to delist its Class A common stock and publicly traded warrants. This move comes as part of...
Continue Reading
Your Gateway to High Returns in Crypto Staking As the digital currency landscape continues to expand, platforms like Keynode.net are leading the charge in offering unprecedented opportunities for investors. For those seeking impressive annual percentage yields (APY) through crypto staking, Keynode.net has emerged as a premier choice. Its user-friendly interface, robust...
Continue Reading
Overview of the Class Action Lawsuit Against Rocket Pharmaceuticals Pomerantz LLP has initiated a class action lawsuit against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) highlighting various concerns regarding the company's business practices. Investors who have suffered losses during the stipulated Class Period should take note of this unfolding situation. Key Details...
Continue Reading
Revitalizing Economic Growth at the 23rd SMDO Conference The 23rd Annual South Metro Development Outlook (SMDO25) Conference stands as a pivotal forum for industry leaders, policymakers, and community stakeholders. It is designed to foster collaboration and tackle some of the most pressing issues faced by the region today. Set against the backdrop of changing federal...
Continue Reading
Strong First Quarter Results for SciBase In the recent interim report, SciBase has showcased an impressive performance for the first quarter of 2025. The medical technology company, renowned for its innovative dermatological solutions, recorded net sales of TSEK 8,856, marking a remarkable increase of 46% from the previous year’s figures. Financial Performance Overview...
Continue Reading